Baijin Life Science Holdings Limited (HKG:1466)

Hong Kong · Delayed Price · Currency is HKD

0.9300

-0.0200 (-2.11%)

Jul 31, 2026, 3:59 PM HKT

34.78% (1Y)

Market Cap	839.03M +57.4%
Revenue (ttm)	89.30M -34.1%
Net Income	-37.87M
EPS	-0.06
Shares Out	932.25M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	88,000
Open	0.8700
Previous Close	0.9500
Day's Range	0.8700 - 0.9300
52-Week Range	0.4650 - 1.7000
Beta	-0.32
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About HKG:1466

Baijin Life Science Holdings Limited, an investment holding company, engages in the purchase, processing, design, production, assembly, trading, and wholesale distribution of jewelry products. The company operates through three segments: Jewellery Business, Strategic Investment, and Skincare Business. It is involved in the real estate financial assets investment business. The company also offers skincare solutions under the FO brand name; franchise licensing and consultation services; consultation and research and development services; skincare... [Read more]

Industry Luxury Goods

Sector Consumer Discretionary

Founded 2014

Employees 84

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 1466

Full Company Profile

Financial Performance

In fiscal year 2026, HKG:1466's revenue was 89.30 million, a decrease of -34.12% compared to the previous year's 135.56 million. Losses were -37.87 million, 11883.2% more than in 2025.

Financial Statements